CLOs on the Move

Inozyme

www.inozyme.com

 
We are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.inozyme.com
  • 321 Summer Street Suite 400
    Boston, MA USA 02210
  • Phone: 857.330.4340

Executives

Name Title Contact Details
Kevin Johnson
 Senior Vice President of Regulatory Affairs Profile
Kevin Johnson
 Senior Vice President of Global Regulatory Affairs, Quality and Product Development Profile

Similar Companies

SimQuest

SimQuest is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ViroPharma Incorporated

ViroPharma Incorporated is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Superbrewed Food

Powerpollen

PowerPollen offers a breakthrough, scalable technology to collect, preserve and apply pollen on-demand to help improve the productivity, profitability and sustainability of modern farming practices.

Proton Laboratories

Proton Laboratories, Inc is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.